Comparison

NFKBIB (nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor. beta)

Item no. 18-003-42541
Manufacturer GENWAY
Amount 0.1 mg
Category
Type Peptides
Applications WB
Specific against other
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias GWB-FA9A82
Similar products 18-003-42541
Available
Genway ID:
GWB-FA9A82
Antigen Specificity:
Polyclonal antibody produced in rabbits immunized with a synthetic peptide corresponding to a region of Human NFKBIB.
ELISA Titre:
1:62500
Note:
Suggested starting concentrations are provided. Optimal dilutions should be determined by end-user. Differences in calculated versus apparent molecular weight may be due to post-translational modifications or protein hydrophobicity. Inhibition of NFkappa-B activity by the hepatitis C virus core protein might be related to its physical interaction with and interrupted nuclear localization of IKKbeta. Increased nuclear factor-kappaB (NF-kB) activity in the amnion during labor is associ
Function:
Inhibits NF-kappa-B by complexing with and trapping it in the cytoplasm. However the unphosphorylated form resynthesized after cell stimulation is able to bind NF-kappa-B allowing its transport to the nucleus and protecting it to further IKBA-dependent inactivation. Association with inhibitor kappa B-interacting NKIRAS1 and NKIRAS2 prevent its phosphorylation rendering it more resistant to degradation explaining its slower degradation.
Subunit:
Interacts with THRB (via ligand-binding domain). Interacts with RELA and REL. Interacts with COMMD1 and inhibitor kappa B-interacting Ras-like NKIRAS1 and NKIRAS2.
Subcellular Location:
Cytoplasm (By similarity). Nucleus (By similarity).
Tissue Specificity:
Expressed in all tissues examined.
Ptm:
Phosphorylated; followed by degradation. Interaction with NKIRAS1 and NKIRAS2 probably prevents phosphorylation.
Similarity:
Belongs to the NF-kappa-B inhibitor family.
Similarity:
Contains 6 ANK repeats. Summary: NFKB1 (MIM 164011) or NFKB2 (MIM 164012) is bound to REL (MIM 164910) RELA (MIM 164014) or RELB (MIM 604758) to form the NFKB complex. The NFKB complex is inhibited by I-kappa-B proteins (NFKBIA MIM 164008 or NFKBIB) which inactivate NF-kappa-B by trapping it in the cytoplasm. Phosphorylation of serine residues on the I-kappa-B proteins by kinases (IKBKA MIM 600664 or IKBKB MIM 603258) marks them for destruction via the ubiquitination pathway thereby allowing activation of the NF-kappa-B complex. Activated NFKB complex translocates into the nucleus and binds DNA at kappa-B-binding motifs such as 5-prime GGGRNNYYCC 3-prime or 5-prime HGGARNYYCC 3-prime (where H is A C or T; R is an A or G purine; and Y is a C or T pyrimidine). [supplied by OMIM]. Lee. Y. . et al. . (2003) Mol. Hum. Reprod. 9 (4). 213-218.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 0.1 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close